BIOMAT Database Logo BIOMAT Database Logo

Intravenous gammaglobulin for adult Kawasaki disease. 1985

P Chavanet, and H Portier, and F Escalier, and B Courtois

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D009080 Mucocutaneous Lymph Node Syndrome An acute, febrile, mucocutaneous condition accompanied by swelling of cervical lymph nodes in infants and young children. The principal symptoms are fever, congestion of the ocular conjunctivae, reddening of the lips and oral cavity, protuberance of tongue papillae, and edema or erythema of the extremities. Kawasaki Disease,Lymph Node Syndrome, Mucocutaneous,Kawasaki Syndrome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

P Chavanet, and H Portier, and F Escalier, and B Courtois
High-dose intravenous gammaglobulin for Kawasaki disease.
November 1984, Lancet (London, England),
P Chavanet, and H Portier, and F Escalier, and B Courtois
High-dose intravenous gammaglobulin for Kawasaki disease.
December 1983, Lancet (London, England),
P Chavanet, and H Portier, and F Escalier, and B Courtois
Initial intravenous gammaglobulin treatment failure in Kawasaki disease.
June 2000, Pediatrics,
P Chavanet, and H Portier, and F Escalier, and B Courtois
Management and outcome of intravenous gammaglobulin-resistant Kawasaki disease.
September 2006, Singapore medical journal,
P Chavanet, and H Portier, and F Escalier, and B Courtois
Late intravenous gammaglobulin treatment in Kawasaki syndrome.
May 1992, Archives of disease in childhood,
P Chavanet, and H Portier, and F Escalier, and B Courtois
High-dose gammaglobulin therapy for Kawasaki disease.
May 1987, The Journal of pediatrics,
P Chavanet, and H Portier, and F Escalier, and B Courtois
Reduction of peripheral blood macrophages/monocytes in Kawasaki disease by intravenous gammaglobulin.
November 1990, European journal of pediatrics,
P Chavanet, and H Portier, and F Escalier, and B Courtois
Intravenous gammaglobulin and reduction of coronary artery abnormalities in children with Kawasaki Disease.
October 1988, Lancet (London, England),
P Chavanet, and H Portier, and F Escalier, and B Courtois
[Immunoregulatory mechanisms of action of intravenous gammaglobulin in Kawasaki syndrome].
January 1998, Przeglad lekarski,
P Chavanet, and H Portier, and F Escalier, and B Courtois
[Coronary arteritis of Kawasaki disease unresponsive to high-dose intravenous gammaglobulin successfully treated with plasmapheresis].
June 1995, Nihon Rinsho Men'eki Gakkai kaishi = Japanese journal of clinical immunology,
Copied contents to your clipboard!